NM_001352514.2(HLCS):c.601G>C (p.Glu201Gln) AND Inborn genetic diseases

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jun 13, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004020253.1

Allele description [Variation Report for NM_001352514.2(HLCS):c.601G>C (p.Glu201Gln)]

NM_001352514.2(HLCS):c.601G>C (p.Glu201Gln)

Gene:

HLCS:holocarboxylase synthetase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

21q22.13

Genomic location:

Preferred name:

NM_001352514.2(HLCS):c.601G>C (p.Glu201Gln)

Other names:

p.E54Q:GAG>CAG

HGVS:

NC_000021.9:g.36937285C>G
NG_016193.2:g.58110G>C
NM_000411.8:c.160G>C
NM_001242784.3:c.160G>C
NM_001242785.2:c.160G>C
NM_001352514.2:c.601G>CMANE SELECT
NM_001352515.2:c.160G>C
NM_001352516.2:c.160G>C
NM_001352517.1:c.160G>C
NM_001352518.2:c.160G>C
NP_000402.3:p.Glu54Gln
NP_001229713.1:p.Glu54Gln
NP_001229714.1:p.Glu54Gln
NP_001339443.1:p.Glu201Gln
NP_001339444.1:p.Glu54Gln
NP_001339445.1:p.Glu54Gln
NP_001339446.1:p.Glu54Gln
NP_001339447.1:p.Glu54Gln
NC_000021.8:g.38309585C>G
NM_000411.6:c.160G>C
NR_148020.2:n.460G>C
NR_148021.1:n.617G>C

Protein change:

E201Q

Links:

dbSNP: rs373822815

NCBI 1000 Genomes Browser:

rs373822815

Molecular consequence:

NM_000411.8:c.160G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001242784.3:c.160G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001242785.2:c.160G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001352514.2:c.601G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001352515.2:c.160G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001352516.2:c.160G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001352517.1:c.160G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001352518.2:c.160G>C - missense variant - [Sequence Ontology: SO:0001583]
NR_148020.2:n.460G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_148021.1:n.617G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Inborn genetic diseases
Identifiers:: MeSH: D030342; MedGen: C0950123

Recent activity

Clear Turn Off Turn On

Streptococcus
Streptococcus
A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animal...<br/>

MeSH

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004882380	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Jun 13, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004882380

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Jun 13, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV004882380.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.160G>C (p.E54Q) alteration is located in exon 5 (coding exon 2) of the HLCS gene. This alteration results from a G to C substitution at nucleotide position 160, causing the glutamic acid (E) at amino acid position 54 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine